Madrigal Pharmaceuticals logo

Madrigal Pharmaceuticals Share Price Today

(NASDAQ: MDGL)

Madrigal Pharmaceuticals share price is $347.28 & ₹30,202.59 as on 6 Mar 2025, 2.30 'hrs' IST

$347.28

25.96

(8.08%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Madrigal Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Madrigal Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Madrigal Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Madrigal Pharmaceuticals share price movements

  • Today's Low: $320.28
    Today's High: $348.48

    Day's Volatility :8.09%

  • 52 Weeks Low: $189.00
    52 Weeks High: $377.46

    52 Weeks Volatility :49.93%

Madrigal Pharmaceuticals (MDGL) Returns

PeriodMadrigal Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
2.64%
2.1%
0.0%
6 Months
30.62%
-4.1%
0.0%
1 Year
24.84%
2.2%
0.0%
3 Years
243.92%
11.8%
-11.6%

Madrigal Pharmaceuticals (MDGL) Key Statistics

in dollars & INR

Previous Close
$321.32
Open
$324.0
Today's High
$348.48
Today's Low
$320.28
Market Capitalization
$6.9B
Today's Volume
$189.5K
52 Week High
$377.46
52 Week Low
$189.0
Revenue TTM
$180.1M
EBITDA
$-496.8M
Earnings Per Share (EPS)
$-21.91
Profit Margin
-258.64%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-80.35%

How to invest in Madrigal Pharmaceuticals Stock (MDGL) from India?

It is very easy for Indian residents to invest directly in Madrigal Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Madrigal Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Madrigal Pharmaceuticals or MDGL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Madrigal Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Madrigal Pharmaceuticals shares which would translate to 0.003 fractional shares of Madrigal Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Madrigal Pharmaceuticals, in just a few clicks!

Returns in Madrigal Pharmaceuticals (MDGL) for Indian investors in Rupees

The Madrigal Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Madrigal Pharmaceuticals investment value today

Current value as on today

₹1,39,892

Returns

₹39,892

(+39.89%)

Returns from Madrigal Pharmaceuticals Stock

₹34,929 (+34.93%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Madrigal Pharmaceuticals (MDGL)

21%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Madrigal Pharmaceuticals Stock from India on INDmoney has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Madrigal Pharmaceuticals

  • HHG PLC

    10.00%

  • Paulson & Company Inc

    9.25%

  • venBio Select Advisor LLC

    9.19%

  • RTW INVESTMENTS, LLC

    9.03%

  • Baker Bros Advisors LP

    8.94%

  • Vanguard Group Inc

    7.73%

Analyst Recommendation on Madrigal Pharmaceuticals

Buy

    80%Buy

    14%Hold

    4%Sell

Based on 21 Wall street analysts offering stock ratings for Madrigal Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
17
16
Hold
3
3
3
Sell
1
0
0

Analyst Forecast on Madrigal Pharmaceuticals Stock (MDGL)

What analysts predicted

Upside of 15.66%

Target:

$401.67

Current:

$347.28

Insights on Madrigal Pharmaceuticals Stock (Ticker Symbol: MDGL)

  • Price Movement

    In the last 3 years, MDGL stock has moved up by 252.2%
  • MDGL vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 33.0%
  • Price to Sales

    ForMDGL every $1 of sales, investors are willing to pay $37.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Madrigal Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Madrigal Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Madrigal Pharmaceuticals (MDGL) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Madrigal Pharmaceuticals, Inc. logo
-1.28%
30.62%
24.84%
243.92%
296.94%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Madrigal Pharmaceuticals, Inc. logo
NA
NA
0.0
-12.58
-0.8
-0.37
NA
34.28
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Madrigal Pharmaceuticals, Inc. logo
Buy
$6.9B
296.94%
NA
-258.64%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

Madrigal Pharmaceuticals Dividend announcements

  • Madrigal Pharmaceuticals Earnings

    Madrigal Pharmaceuticals’s price-to-earnings ratio stands at None

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.
Organization
Madrigal Pharmaceuticals
Employees
528
CEO
Mr. William J. Sibold
Industry
Health Technology

Management People of Madrigal Pharmaceuticals

NameTitle
Mr. William J. Sibold
CEO, President & Director
Dr. Rebecca A. Taub M.D.
Founder, Chief Medical Officer, President of Research & Development and Director
Ms. Carole Huntsman
Chief Commercial Officer
Ms. Mardi C. Dier
CFO & Senior VP
Mr. Mark Underwood
Senior Vice President of Business Planning & Operations
Mr. Ronald Filippo
Chief Information Officer
Ms. Tina E. Ventura
Chief Investor Relations Officer
Ms. Shannon Kelley
General Counsel
Mr. Clint Wallace
Chief Human Resources Officer
Mr. Edward Chiang
Senior Vice President of Clinical & Technical Operations

Important FAQs about investing in MDGL Stock from India :

What is Madrigal Pharmaceuticals share price today?

Madrigal Pharmaceuticals share price today stands at $347.28, Open: $324.00 ; Previous Close: $321.32 ; High: $348.48 ; Low: $320.28 ; 52 Week High: $377.46 ; 52 Week Low: $189.00.

The stock opens at $324.00, after a previous close of $321.32. The stock reached a daily high of $348.48 and a low of $320.28, with a 52-week high of $377.46 and a 52-week low of $189.00.

Can Indians buy Madrigal Pharmaceuticals shares?

Yes, Indians can invest in the Madrigal Pharmaceuticals (MDGL) from India.

With INDmoney, you can buy Madrigal Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Madrigal Pharmaceuticals at zero transaction cost.

How can I buy Madrigal Pharmaceuticals shares from India?

It is very easy to buy Madrigal Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Madrigal Pharmaceuticals (MDGL) be purchased?

Yes, you can buy fractional shares of Madrigal Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Madrigal Pharmaceuticals stocks?

To start investing in Madrigal Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Madrigal Pharmaceuticals Stock (MDGL)?

Today’s highest price of Madrigal Pharmaceuticals (MDGL) is $348.48.

Today’s lowest price of Madrigal Pharmaceuticals (MDGL) is $320.28.

What is today's market capitalisation of Madrigal Pharmaceuticals?

Today's market capitalisation of Madrigal Pharmaceuticals MDGL is 6.9B

What is the 52 Week High and Low Range of Madrigal Pharmaceuticals Stock (MDGL)?

  • 52 Week High

    $377.46

  • 52 Week Low

    $189.00

What are the historical returns of Madrigal Pharmaceuticals (MDGL)?

  • 1 Month Returns

    -1.28%

  • 3 Months Returns

    30.62%

  • 1 Year Returns

    24.84%

  • 5 Years Returns

    296.94%

Who is the Chief Executive Officer (CEO) of Madrigal Pharmaceuticals ?

Mr. William J. Sibold is the current Chief Executive Officer (CEO) of Madrigal Pharmaceuticals.